{
    "organizations": [],
    "uuid": "d3c7731d0455d2cda3379e428a21ecde4782674e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-gb-sciences-pursues-fda-registered/brief-gb-sciences-pursues-fda-registered-first-in-human-trial-of-cannabis-based-therapy-for-parkinsons-disease-idUSFWN1RN06W",
    "ord_in_thread": 0,
    "title": "BRIEF-GB Sciences Pursues FDA-Registered, First-In-Human Trial Of Cannabis Based Therapy For Parkinson's Disease",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - GB Sciences Inc:\n* BASED THERAPY FOR PARKINSONâ€™S DISEASE * EXPECTS TO COMMENCE ITS FIRST-IN-HUMAN TRIAL IN EARLY 2019\n* COMPANY WILL BEGIN ITS TOXICOLOGY STUDIES IN SUMMER OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-10T12:35:00.000+03:00",
    "crawled": "2018-04-10T12:49:33.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "gb",
        "science",
        "inc",
        "based",
        "therapy",
        "parkinson",
        "disease",
        "expects",
        "commence",
        "trial",
        "early",
        "company",
        "begin",
        "toxicology",
        "study",
        "summer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}